Adriamycin (doxorubicin)
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Adriamycin (doxorubicin), covering 2011-09-12 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma [Phase 2]